Adetayo Odueke

Researcher

Last publication 2025 Last refreshed 2026-05-16

unknown

1 h-index 8 pubs 17 cited

Biography and Research Information

OverviewAI-generated summary

Adetayo Odueke's research focuses on cardiovascular health, particularly in the context of complex medical conditions and emerging therapies. Recent publications explore molecular insights into ischemia-reperfusion injury and advances in non-statin lipid therapies for cardiovascular risk reduction. Odueke has investigated cardiotoxicity surveillance in targeted immunotherapy, specifically the Cytokine Release Syndrome as a trigger for cardiac dysfunction after CAR-T therapy, and has examined predictors of adverse cardiovascular events following this treatment. Further work includes a case report on bivalvular endocarditis in a hemodialysis patient and studies on the significance of ischemic electrocardiogram changes in dobutamine stress echocardiography. Odueke also published research on the safety of Class 1C antiarrhythmic drugs in patients with arrhythmia-induced cardiomyopathy. Collaborations include work with J. Curran Henson, Ryan Pohlkamp, Malek Alaiwah, and Robert Spraggins at the University of Arkansas for Medical Sciences.

Metrics

  • h-index: 1
  • Publications: 8
  • Citations: 17

Selected Publications

  • TCT-262 Five-Year Mortality Comparison of Left Ventricular Unloading Devices for Individuals with Cardiogenic Shock on VA-ECMO (2025)
  • Advances in Non-statin Lipid Therapies: A Narrative Review of Evolving Strategies for Cardiovascular Risk Reduction (2025)
    1 citation DOI OpenAlex
  • PREDICTORS OF ADVERSE CARDIOVASCULAR EVENTS AFTER CHIMERIC ANTIGEN T-CELL (CAR-T) THERAPY (2025)
  • SIGNIFICANCE OF ISCHEMIC ELECTROCARDIOGRAM CHANGES IN THE SETTING OF NORMAL IMAGING IN DOBUTAMINE STRESS ECHOCARDIOGRAPHY (2025)
  • Molecular Insights into Ischemia–Reperfusion Injury in Coronary Artery Disease: Mechanisms and Therapeutic Implications: A Comprehensive Review (2025)
    12 citations DOI OpenAlex
  • Abstract 4146588: Class 1C Antiarrhythmic Drugs are Safe in Patients with Arrhythmia-induced Cardiomyopathy Following Recovery of Left Ventricular Ejection Fraction (2024)
  • A Rapidly Deteriorating Case of Bivalvular Endocarditis in a Hemodialysis Patient: A Case Report (2024)
    1 citation DOI OpenAlex

View all publications on OpenAlex →

Collaboration Network

56 Collaborators 20 Institutions 4 Countries

Top Collaborators

View profile →
View profile →
View profile →
View profile →
View profile →
View profile →
View profile →

Similar Researchers

Based on overlapping research topics